Prediction: Pfizer Stock Could Double If Pipeline Delivers
Pfizer stock is navigating a pivot from COVID-era revenues to a broader drug portfolio. Analysts weigh the odds of a ...
Uncover which cash back cards come with no annual fee. Choose the best option for your spending habits!
27,852 articlesPfizer stock is navigating a pivot from COVID-era revenues to a broader drug portfolio. Analysts weigh the odds of a ...
PIMCO dismisses Trump’s NATO exit threats as noise, calling them a paper tiger. The note arrives as investors weigh t...
Bitcoin just dropped below 60K, prompting a careful look at what happens next. This guide uses historical patterns to...
Chipotle and Microsoft have taken divergent paths in 2026. CMG rides restaurant-demand strength while MSFT grapples w...
Trilogy Metals has fallen hard this week, leaving investors asking whether the downturn is a short-lived pullback or ...
Newmont faced a sharp one-day decline as gold trends shifted and market risks crept in. This article breaks down the ...
Adobe stock is staging a comeback after a brutal selloff, with stronger earnings and AI-driven growth fueling optimis...
Netflix is set to release its Q2 earnings after the bell tonight, with investors watching ad revenue growth, content ...
When space tech hype cools and SpaceX shares fall below, savvy investors weigh whether a dip is a buying signal or a ...
Eli Lilly stock could advance in the second half of 2026 as Foundayo gains traction and the GLP-1 franchise shines, b...
Automakers report record truck profits even as they book a roughly $7 billion charge tied to exiting certain EV progr...
VR Adviser recently disclosed a substantial sale of Ocular Therapeutix shares, triggering questions about what it mea...